Biology of Bone Metastases in Patients With mCRPC

Video

In Partnership With:

Conor Lynch, PhD, an associate professor of Tumor Biology at Moffitt Cancer Center, discusses the biology of bone metastases in patients with castration-resistant prostate cancer.

Conor Lynch, PhD, an associate professor of Tumor Biology at Moffitt Cancer Center, discusses the biology of bone metastases in patients with metastatic castration-resistant prostate cancer.

When prostate cancer metastasizes, it typically spreads to the bone, Lynch explains. Researchers at Moffitt Cancer Center, particularly in Lynch's lab, are investigating how cancer cells metastasize to the bone and how they interact with the bone environment in order to grow.

These metastases can lead to extensive bone formation, which are osteosclerotic types of lesions that often occur in areas of the patients who are weight-bearing. These can be extremely painful and greatly affect patient quality of life, he adds.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD